AAAAAA

   
Results: 1-15 |
Results: 15
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER
Authors: BOLIS G FAVALLI G DANESE S ZANABONI F MANGILI G SCARABELLI C TATEO S VALSECCHI MG SCARFONE G RICHIARDI G FRIGERIO I MELPIGNANO M VILLA A PARAZZINI F
Citation: G. Bolis et al., WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1938-1944
THE ROLE OF INTERVENTION DEBULKING SURGERY IN ADVANCED EPITHELIAL OVARIAN-CANCER - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY
Authors: VANDERBERG MEL VANLENT M BUYSE M KOBIERSKA A MAGGIONI A FAVALLI G LACAVE AJ NARDI M RENARD J PECORELLI S
Citation: Mel. Vanderberg et al., THE ROLE OF INTERVENTION DEBULKING SURGERY IN ADVANCED EPITHELIAL OVARIAN-CANCER - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY, International journal of gynecological cancer, 6, 1996, pp. 30-38
TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY
Authors: CREEMERS GJ BOLIS G GORE M SCARFONE G LACAVE AJ GUASTALLA JP DESPAX R FAVALLI G KREINBERG R VANBELLE S HUDSON I VERWEIJ J HUININK WWT
Citation: Gj. Creemers et al., TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY, Journal of clinical oncology, 14(12), 1996, pp. 3056-3061
PHASE-II STUDY OF CISPLATIN (P), VINBLASTINE (V) AND BLEOMYCIN (B) INRECURRENT OR ADVANCED DYSGERMINOMA (D)
Authors: VANOOSTEROM AT FAVALLI G KOBIESKA A PAWINSKY A SAHMOUD T PECORELLI S
Citation: At. Vanoosterom et al., PHASE-II STUDY OF CISPLATIN (P), VINBLASTINE (V) AND BLEOMYCIN (B) INRECURRENT OR ADVANCED DYSGERMINOMA (D), European journal of cancer, 31A, 1995, pp. 515-515
ONDANSETRON VS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: ROILA F DEANGELIS V MORETTI G TATEO S CASCINU S IONTA MT MONTINARI F MORRITTI M PUSCEDDU G FAVALLI G CORTESI E DAZZI C BALLATORI E
Citation: F. Roila et al., ONDANSETRON VS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, European journal of cancer, 31A, 1995, pp. 1226-1226
ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32)
Authors: BOLIS G COLOMBO N PECORELLI S TORRI V MARSONI S BONAZZI C CHIARI S FAVALLI G MANGILI C PRESTI M ZANABONI F MANGIONI C
Citation: G. Bolis et al., ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32), Annals of oncology, 6(9), 1995, pp. 887-893
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: VANDERBURG MEL VANLENT M BUYSE M KOBIERSKA A COLOMBO N FAVALLI G LACAVE AJ NARDI M RENARD J PECORELLI S
Citation: Mel. Vanderburg et al., THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN-CANCER, The New England journal of medicine, 332(10), 1995, pp. 629-634
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY
Authors: DEANGELIS V BALLATORI E ROILA F TONATO M DELFAVERO A BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: V. Deangelis et al., ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY, Supportive care in cancer, 2(3), 1994, pp. 171-176
CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES
Authors: ROILA F TONATO M DEANGELIS V BALLATORI E OLIVIERI A DELFAVERO A BASURTO C CORGNA E PICCIAFUOCO M PALLADINO MA CICCARESE G FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F CERCATO MC BUZZI F TRIPPA F SABBATINI R SILINGARDI V MATERA G GRAMAZIO A DAZZI C MARANGOLO M LEONARDI M CANALETTI R TATEO S ZARA C DONATI D SANSONI E FERRARI M
Citation: F. Roila et al., CISPLATIN-INDUCED DELAYED EMESIS - PATTERN AND PROGNOSTIC FACTORS DURING 3 SUBSEQUENT CYCLES, Annals of oncology, 5(7), 1994, pp. 585-589
CARBOPLATIN VERSUS CISPLATIN
Authors: VERMORKEN JB HUININK WWT EISENHAUER EA FAVALLI G BELPOMME D CONTE PF KAYE SB
Citation: Jb. Vermorken et al., CARBOPLATIN VERSUS CISPLATIN, Annals of oncology, 4, 1993, pp. 41-48
ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS
Authors: ALLEN DG BAAK J BELPOMME D BEREK JS BERTELSEN K HUININK WWT VANDERBURG MEL CALVERT AH CONTE PE DAUPLAT J EISENHAUER EA FAVALLI G HACKER NF HAMILTON TC HANSEN HH HANSEN M VANHOUWELINGEN HC KAYE SB LEVIN L LUND B NEIJT JP OZOLS RF PICCART MJ RUSTIN GJS SESSA C SOUTTER WP THIGPEN JT TROPE C VERMORKEN JB DEVRIES EGE
Citation: Dg. Allen et al., ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS, Annals of oncology, 4, 1993, pp. 83-88
THE ROLE OF SONOGRAPHICALLY GUIDED ASPIRATION IN THE CLINICAL MANAGEMENT OF OVARIAN CYSTS
Authors: DORDONI D ZAGLIO S ZUCCA S FAVALLI G
Citation: D. Dordoni et al., THE ROLE OF SONOGRAPHICALLY GUIDED ASPIRATION IN THE CLINICAL MANAGEMENT OF OVARIAN CYSTS, Journal of ultrasound in medicine, 12(1), 1993, pp. 27-31
Risultati: 1-15 |